Journal of Dermatology Research and Skin Care

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Research Article - Journal of Dermatology Research and Skin Care (2023) Volume 7, Issue 3

Positive effects of Nourkrin® Woman with Marilex® on hair growth and appearance leads to a high level of patient satisfaction-A Clinical study on women with diffuse hair loss from the Arabian countries of the Gulf Cooperation Council.

Proteoglycan replacement therapy (PRT) is an emerging anti hair loss treatment that utilises a targeted complex of bioactive proteoglycans (Marilex®) to stimulate anagen and maintain active growth in affected hair follicles with Female Pattern Hair Loss (FPHL) and Telogen Effluvium (TE). Nourkrin® with Marilex® increases the concentration of follicular proteoglycans and thereby prevents and treats hair loss and miniaturisation caused by Proteoglycan Follicular Atrophy (PFA). PFA is known to be a key pathology behind diffuse hair loss. The current study aimed to evaluate the treatment satisfaction rate of PRT with Nourkrin® in female patients residing in the Arab countries of the Gulf Cooperation Council. 108 female individuals with diffuse hair loss (average age = 34.31 years) were enrolled into a longitudinal cohort study. The participants voluntarily started a 6-month course of monotherapy with Nourkrin® Woman (600 mg Marilex® per day) and were monitored every 3 months using a semi-structured questionnaire. Enrolment and follow-ups were carried out in collaboration with the World Hair Council. 84% of volunteers were presented with moderate to severe diffuse hair loss of whom more than half had not received medical treatment before. 84.26% and 68.52% of subjects reported improvements in their hair growth and appearance, and 86.11% felt more confident with their hair after 3 months of using Nourkrin® Woman. Patient satisfaction rate was at 89.81% at study mid-point. Out of the 101 participants who had finished the study, 95.05% found their hair growth and appearance improved, which also enhanced their self-confidence. Continuing Nourkrin® therapy for 6 months enhanced treatment satisfaction rate by 8%, denoting the importance of time in achieving optimal clinical results. Overall, our findings confirm that PRT with Nourkrin® is effective in improving both hair growth and appearance as reported by hair loss patients. Nourkrin® efficacy and satisfaction rate was comparable with the previously studied European and Latin American populations.

Author(s): Jan Wadstein*, Fahad Abdulaziz Almutawa, Haitham Al-Ramal.

Abstract Full Text PDF

Get the App